Published in Invest Ophthalmol Vis Sci on August 07, 2013
ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration. Cell Rep (2015) 0.97
Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci (2016) 0.97
Parainflammation, chronic inflammation, and age-related macular degeneration. J Leukoc Biol (2015) 0.94
Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. Prog Retin Eye Res (2015) 0.90
Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol (2015) 0.90
The immune response after fracture trauma is different in old compared to young patients. Immun Ageing (2014) 0.79
How Mouse Macrophages Sense What Is Going On. Front Immunol (2016) 0.78
Macrophages coming of age: their role in promoting CNV is modulated by FasL. Invest Ophthalmol Vis Sci (2013) 0.76
Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms. Angiogenesis (2016) 0.75
Protective Effect of Met12, a Small Peptide Inhibitor of Fas, on the Retinal Pigment Epithelium and Photoreceptor After Sodium Iodate Injury. Invest Ophthalmol Vis Sci (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
The Fas death factor. Science (1995) 13.81
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest (2007) 9.09
Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (1995) 8.23
Age-related macular degeneration. N Engl J Med (2008) 7.49
Macrophage polarization comes of age. Immunity (2005) 5.67
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 5.60
Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol (2004) 5.14
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A (2004) 4.84
The many roles of FAS receptor signaling in the immune system. Immunity (2009) 4.67
RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res (2005) 3.52
Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.17
The CD95 receptor: apoptosis revisited. Cell (2007) 3.13
Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.04
Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res (2001) 2.87
Para-inflammation in the aging retina. Prog Retin Eye Res (2009) 2.71
Mechanisms of age-related macular degeneration. Neuron (2012) 2.62
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature (2009) 2.54
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med (2006) 2.18
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity (1996) 2.06
CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity (2010) 1.91
The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol (2003) 1.84
Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest (2007) 1.72
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest (1997) 1.69
Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev (2005) 1.64
Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int (2011) 1.62
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A (2005) 1.54
Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res (2005) 1.50
Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol (2009) 1.49
Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J (2008) 1.46
ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ (2007) 1.46
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J (2003) 1.42
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res (2010) 1.39
Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell (2008) 1.37
Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys (2002) 1.35
Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci (2006) 1.32
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol (2007) 1.31
Chemotactic activity of soluble Fas ligand against phagocytes. J Immunol (1998) 1.30
Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology (2010) 1.30
Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr Drug Targets (2011) 1.27
Dendritic cell physiology and function in the eye. Immunol Rev (2010) 1.24
The immune system in the aging human. Immunol Res (2012) 1.24
Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2002) 1.23
Doxycycline treatment prevents alveolar destruction in VEGF-deficient mouse lung. J Cell Biochem (2008) 1.19
CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation (2010) 1.18
Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med (1999) 1.18
Absence of inhibition of cutaneous wound healing in mice by oral doxycycline. Wound Repair Regen (2003) 1.18
A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev (2006) 1.17
Dendritic cells and macrophages in the uveal tract of the normal mouse eye. Br J Ophthalmol (1999) 1.16
Impaired apoptosis and immune senescence - cause or effect? Immunol Rev (2005) 1.11
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy. Clin Cancer Res (2005) 1.06
Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1998) 1.05
Doxycycline attenuates isoproterenol- and transverse aortic banding-induced cardiac hypertrophy in mice. J Pharmacol Exp Ther (2007) 1.04
Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci (2007) 1.03
Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344. PLoS One (2011) 1.01
FasL-Fas interactions regulate neovascularization in the cornea. Invest Ophthalmol Vis Sci (2003) 1.01
Angiogenesis in eye disease: immunity gained or immunity lost? Semin Immunopathol (2008) 1.00
Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo. J Immunol (2004) 0.99
Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol (1990) 0.97
Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLoS One (2011) 0.96
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization. FASEB J (2006) 0.95
Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cell Mol Life Sci (2010) 0.94
Targeting immune privilege to prevent pathogenic neovascularization. Invest Ophthalmol Vis Sci (2010) 0.92
Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.91
Conditions of retinal glial and inflammatory cell activation after irradiation in a GFP-chimeric mouse model. Invest Ophthalmol Vis Sci (2010) 0.90
Effect of metalloprotease inhibitors on corneal allograft survival. Invest Ophthalmol Vis Sci (2004) 0.89
Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br J Ophthalmol (2007) 0.89
Associations of plasma-soluble fas ligand with aging and age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 0.87
The role of Fas-FasL in the development and treatment of ischemic retinopathy. Invest Ophthalmol Vis Sci (2003) 0.86
Fas-ligand and immune privilege: the eyes have it. Cell Death Differ (2001) 0.85
Serum levels of sFas and sFasL during chemotherapy of lung cancer. Exp Oncol (2007) 0.80
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer. Cancer (2013) 0.78
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity (2008) 4.37
The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci (2012) 4.11
The sepsis seesaw: tilting toward immunosuppression. Nat Med (2009) 3.95
Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med (2002) 2.34
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29
Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice. J Leukoc Biol (2009) 2.27
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med (2006) 2.18
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology (2010) 2.02
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol (2005) 1.98
IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol (2009) 1.91
Noncanonical autophagy promotes the visual cycle. Cell (2013) 1.74
Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest (2007) 1.72
Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control of CD4+ T-cell responses. J Virol (2009) 1.67
Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood (2004) 1.66
The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood (2005) 1.46
Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab (2013) 1.42
Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol (2006) 1.40
Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. Blood (2005) 1.36
Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol (2007) 1.33
Retinal pigment epithelial tears in ranibizumab-treated eyes. Retina (2009) 1.32
Mechanics of transient platelet adhesion to von Willebrand factor under flow. Biophys J (2004) 1.24
Identification and characterization of small molecules that inhibit intracellular toxin transport. Infect Immun (2007) 1.23
The role of TCR engagement and activation-induced cell death in sepsis-induced T cell apoptosis. J Immunol (2006) 1.22
Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure (2002) 1.21
Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One (2008) 1.17
Identification of an IFN-gamma-producing neutrophil early in the response to Listeria monocytogenes. J Immunol (2009) 1.14
Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J Immunol (2010) 1.13
Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity (2011) 1.13
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration. Ophthalmology (2007) 1.12
Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive. FASEB J (2005) 1.12
TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol (2002) 1.09
Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood (2012) 1.09
Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia. Retina (2006) 1.07
Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci (2004) 1.06
Peripheral deletion of antigen-specific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells. J Immunol (2005) 1.05
Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res (2008) 1.04
Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. Int J Inflam (2013) 1.04
The plasticity of regulatory T cell function. J Immunol (2011) 1.03
Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol (2006) 1.03
FasL-Fas interactions regulate neovascularization in the cornea. Invest Ophthalmol Vis Sci (2003) 1.01
Angiogenesis in eye disease: immunity gained or immunity lost? Semin Immunopathol (2008) 1.00
Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury. J Leukoc Biol (2008) 0.99
Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway. Am J Pathol (2010) 0.96
SCLERAL BUCKLING WITH WIDE-ANGLED ENDOILLUMINATION AS A SURGICAL EDUCATIONAL TOOL. Retina (2016) 0.94
A case of intravitreal silicone oil migration to the central nervous system. Retina (2005) 0.94
Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10. J Immunol (2004) 0.92
Targeting immune privilege to prevent pathogenic neovascularization. Invest Ophthalmol Vis Sci (2010) 0.92
Intravitreal pharmacotherapy: applications in retinal disease. Compr Ophthalmol Update (2008) 0.91
Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. Am J Ophthalmol (2007) 0.91
Biology of FasL. Cytokine Growth Factor Rev (2003) 0.90
Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells. J Immunol (2009) 0.90
Effect of metalloprotease inhibitors on corneal allograft survival. Invest Ophthalmol Vis Sci (2004) 0.89
Spontaneous resolution of an inflammation-associated epiretinal membrane with previously documented posterior vitreous detachment. Br J Ophthalmol (2007) 0.89
Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables. Retina (2009) 0.88
N-acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation. Am J Pathol (2011) 0.88
An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor. J Biol Chem (2014) 0.88
Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy. PLoS One (2009) 0.88
Retrospective analysis of etiopathogenesis of all cases of endophthalmitis at a large tertiary referral center. Int Ophthalmol (2007) 0.88
Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion. Proc Natl Acad Sci U S A (2002) 0.88
Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis. Am J Ophthalmol (2008) 0.87
Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. J Immunol (2010) 0.87
The role of Fas-FasL in the development and treatment of ischemic retinopathy. Invest Ophthalmol Vis Sci (2003) 0.86
Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2012) 0.84
The role of Fas ligand as an effector molecule in corneal graft rejection. Eur J Immunol (2005) 0.83
Bilateral choroiditis from Prototheca wickerhamii algaemia. Arch Ophthalmol (2005) 0.82
Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Trans Am Ophthalmol Soc (2004) 0.82
Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmol (2012) 0.81
TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion. J Leukoc Biol (2010) 0.81
Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina (2004) 0.80
Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine. J Antimicrob Chemother (2007) 0.80
Inhibiting angiogenesis in retinoblastoma. Ophthalmic Res (2007) 0.80
Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function. J Neurosci (2014) 0.79
Short-term intraocular pressure trends after intravitreal triamcinolone injection. Am J Ophthalmol (2006) 0.79
An assay for macrophage-mediated regulation of endothelial cell proliferation. Immunobiology (2008) 0.78
Pattern electroretinography in age-related macular degeneration. Arch Ophthalmol (2011) 0.76
SCOREing in retinal venous occlusive disease. Arch Ophthalmol (2009) 0.76
FasL, leukocytes and vascular modeling. Nat Med (2004) 0.76
Full-thickness macular hole in a patient with proliferative sickle cell retinopathy. Retina (2010) 0.75
Successful treatment of choroidal blastomycosis with oral administration of voriconazole. Can J Ophthalmol (2009) 0.75
Microstructural retinal findings by spectral-domain optical coherence tomography after vitrectomy repair of rhegmatogenous retinal detachments. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain mice. Ocul Immunol Inflamm (2006) 0.75
GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients. JCI Insight (2017) 0.75
Effect of preoperative vitreous status on visual outcomes following vitrectomy for epiretinal membrane repair. Can J Ophthalmol (2011) 0.75
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response. Graefes Arch Clin Exp Ophthalmol (2007) 0.75
Apoptosis: the eyes have it. Adv Exp Med Biol (2002) 0.75
Retinal vascular occlusions and macular thinning in fibromuscular dysplasia. Retin Cases Brief Rep (2010) 0.75